ESR1 and cancer: demonstrated that the levels of expression of AGTR1, AGTR2, vascular endothelial growth factor (VEGF), and estrogen receptor (ER)-α levels varied with the different stages of cancer, concluding a higher expression of AngII receptors in the early grade of EC (1).